Literature DB >> 8081996

Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization, but not protein synthesis of cultured glomerular epithelial cells.

W Coers1, S Huitema, M L van der Horst, J J Weening.   

Abstract

Puromycin aminonucleoside (PA) and Adriamycin (ADR) cause glomerular proteinuria associated with degenerative alterations of glomerular visceral epithelial cells (GVEC) and detachment from the glomerular basement membrane when administered to rats. This in vitro study was performed to define, in detail, the quantitative and qualitative changes of a number of adhesion-associated proteins (cytoskeletal, extracellular matrix and integrin proteins) upon exposure to PA and ADR. By immunofluorescence we observed: (1) dose- and incubation-time-dependent filament pattern changes and decreased staining of the cytoskeletal proteins actin, vimentin, keratin, and beta-tubulin; (2) an altered distribution, and decreased expression of the extracellular matrix proteins laminin and heparan sulfate and (3) a loss of the beta 1-integrin focal adhesions upon exposure to PA and ADR. Using an ELISA, a concentration-dependent decrease was found (a 50% reduction with 50 micrograms/ml PA for 48 h and with 2 micrograms/ml ADR for 24 h) in the production of cytoskeletal and extracellular matrix proteins per cell. These general effects were suggestive of a disturbance of protein synthesis but, by metabolic labelling studies, no reduction in overall protein synthesis was found. Using two-dimensional PAGE on 35S-methionine steady-state labeled cells, no changes were found in intracellular protein patterns of PA- and ADR-treated cells (pH 5-7.5, MW 110-20 kD). We hypothesize that exposure of GVEC in vitro to PA and ADR might result, directly or indirectly, in perturbation of the macromolecular organization of cytoskeletal and extracellular matrix proteins with loss of GVEC adhesion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8081996

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  8 in total

1.  Prkdc participates in mitochondrial genome maintenance and prevents Adriamycin-induced nephropathy in mice.

Authors:  Natalia Papeta; Zongyu Zheng; Eric A Schon; Sonja Brosel; Mehmet M Altintas; Samih H Nasr; Jochen Reiser; Vivette D D'Agati; Ali G Gharavi
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

2.  Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.

Authors:  Bryce A Kerlin; Amanda P Waller; Ruchika Sharma; Melinda A Chanley; Marvin T Nieman; William E Smoyer
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

3.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.

Authors:  P G Conaldi; L Biancone; A Bottelli; A De Martino; G Camussi; A Toniolo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile.

Authors:  Tarak Srivastava; Mukut Sharma; Kok-Hooi Yew; Ram Sharma; R Scott Duncan; Moin A Saleem; Ellen T McCarthy; Alexander Kats; Patricia A Cudmore; Uri S Alon; Christopher J Harrison
Journal:  J Cell Commun Signal       Date:  2012-11-17       Impact factor: 5.782

5.  Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.

Authors:  S Doublier; V Ruotsalainen; G Salvidio; E Lupia; L Biancone; P G Conaldi; P Reponen; K Tryggvason; G Camussi
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

6.  Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases.

Authors:  Maire Beeken; Maja T Lindenmeyer; Simone M Blattner; Victoria Radón; Jun Oh; Tobias N Meyer; Diana Hildebrand; Hartmut Schlüter; Anna T Reinicke; Jan-Hendrik Knop; Anuradha Vivekanandan-Giri; Silvia Münster; Marlies Sachs; Thorsten Wiech; Subramaniam Pennathur; Clemens D Cohen; Matthias Kretzler; Rolf A K Stahl; Catherine Meyer-Schwesinger
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

Review 7.  Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.

Authors:  Roberta Bertelli; Alice Bonanni; Gianluca Caridi; Alberto Canepa; G M Ghiggeri
Journal:  Front Med (Lausanne)       Date:  2018-06-11

8.  Podocytes Produce and Secrete Functional Complement C3 and Complement Factor H.

Authors:  Anne K Mühlig; Lindsay S Keir; Jana C Abt; Hannah S Heidelbach; Rachel Horton; Gavin I Welsh; Catherine Meyer-Schwesinger; Christoph Licht; Richard J Coward; Lars Fester; Moin A Saleem; Jun Oh
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.